Key result
Endothelin receptor blockade in animal models of acute myocardial infarction shows short-term benefits but potential long-term adverse effects, with human data currently lacking.
Why the study?
Does endothelin receptor blockade improve outcomes in acute myocardial infarction?
Does endothelin receptor blockade improve outcomes in acute myocardial infarction?
The endothelin system plays a dual role post-AMI, with short-term receptor blockade showing benefits but long-term inhibition causing adverse remodeling in animal models.
No takes yet. Share an insight, caveat, or question.
Short-term ET blockade benefits in AMI models warrant caution for long-term use; leaves open human efficacy and optimal timing.
Černáček et al. (2003) conducted a review in Acute myocardial infarction. Endothelin receptor blockade was evaluated. Endothelin receptor blockade in animal models of acute myocardial infarction shows short-term benefits but potential long-term adverse effects, with human data currently lacking.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: